BSE Live
Jan 16, 16:01Prev. Close
4020.90
Open Price
4017.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 16, 15:58Prev. Close
4021.50
Open Price
4021.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4164.00 (18)
| Key Financial Ratios of Sanofi India (in Rs. Cr.) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 179.54 | 261.91 | 269.47 | 410.06 | 207.38 | |
| Diluted EPS (Rs.) | 179.54 | 261.91 | 269.47 | 410.06 | 207.38 | |
| Cash EPS (Rs.) | 195.74 | 279.48 | 288.04 | 439.61 | 243.39 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 374.17 | 441.52 | 554.70 | 967.65 | 921.30 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 374.17 | 441.52 | 554.70 | 967.65 | 921.30 | |
| Dividend / Share(Rs.) | 117.00 | 167.00 | 570.00 | 490.00 | 365.00 | |
| Revenue from Operations/Share (Rs.) | 875.30 | 1,239.61 | 1,204.39 | 1,285.48 | 1,261.70 | |
| PBDIT/Share (Rs.) | 220.57 | 377.96 | 337.35 | 363.87 | 349.09 | |
| PBIT/Share (Rs.) | 204.61 | 360.74 | 319.13 | 334.87 | 313.35 | |
| PBT/Share (Rs.) | 187.57 | 367.74 | 375.78 | 546.78 | 294.43 | |
| Net Profit/Share (Rs.) | 179.78 | 262.26 | 269.83 | 410.61 | 207.65 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 25.19 | 30.48 | 28.00 | 28.30 | 27.66 | |
| PBIT Margin (%) | 23.37 | 29.10 | 26.49 | 26.05 | 24.83 | |
| PBT Margin (%) | 21.42 | 29.66 | 31.20 | 42.53 | 23.33 | |
| Net Profit Margin (%) | 20.53 | 21.15 | 22.40 | 31.94 | 16.45 | |
| Return on Networth / Equity (%) | 48.04 | 59.39 | 48.64 | 42.43 | 22.53 | |
| Return on Capital Employed (%) | 52.72 | 77.99 | 55.14 | 33.32 | 32.29 | |
| Return on Assets (%) | 25.65 | 35.16 | 29.95 | 30.85 | 16.36 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 1.21 | 1.51 | 1.08 | 0.99 | 0.94 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.57 | 1.91 | 2.17 | 2.85 | 2.67 | |
| Quick Ratio (X) | 0.87 | 0.89 | 1.62 | 2.33 | 2.13 | |
| Inventory Turnover Ratio (X) | 0.61 | 1.05 | 1.37 | 1.46 | 1.41 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 139.78 | 253.46 | 89.00 | 168.29 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 131.17 | 237.43 | 83.13 | 143.58 | |
| Earnings Retention Ratio (%) | 0.00 | -39.78 | -153.46 | 11.00 | -68.29 | |
| Cash Earnings Retention Ratio (%) | 0.00 | -31.17 | -137.43 | 16.87 | -43.58 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 13,783.39 | 18,149.43 | 12,437.30 | 16,603.60 | 17,922.46 | |
| EV/Net Operating Revenue (X) | 6.85 | 6.37 | 4.49 | 5.62 | 6.18 | |
| EV/EBITDA (X) | 27.17 | 20.88 | 16.03 | 19.84 | 22.32 | |
| MarketCap/Net Operating Revenue (X) | 6.99 | 6.51 | 4.86 | 6.14 | 6.59 | |
| Retention Ratios (%) | 0.00 | -39.78 | -153.46 | 10.99 | -68.29 | |
| Price/BV (X) | 16.36 | 18.27 | 10.55 | 8.16 | 9.03 | |
| Price/Net Operating Revenue | 6.99 | 6.51 | 4.86 | 6.14 | 6.59 | |
| Earnings Yield | 0.03 | 0.03 | 0.05 | 0.05 | 0.02 |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y